Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E.
Other stock markets
 04:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
3.68 CAD -0.54% Intraday chart for Eupraxia Pharmaceuticals Inc. +5.75% -31.47%
Jul. 03 Eupraxia Pharmaceuticals Inc. Brief: Says CEO Dr. James Helliwell to Participate in Webinar Event, 'Exploring the Rapid Rise of Osteoarthritis' on July 9, 2024 MT
Jun. 05 Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024 MT

Evolution of the average Target Price on Eupraxia Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

c.IMwCekUwZy2dUqXIe-li75pVzdOCZgRBgIfAXWwKhFE.YbxrMn1nXx_7A-iSOKcLlvYhu7i0P2we8-aTKiVz4GVOulAiHX0WaOwC9A~a57ac006f990271900e4f86c8dcd3dbe

Analyst Recommendations on Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Rated Outperform, $7 Target Price at Raymond James MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.68 CAD
Average target price
15.13 CAD
Spread / Average Target
+311.23%
High Price Target
16.5 CAD
Spread / Highest target
+348.37%
Low Price Target
12.4 CAD
Spread / Lowest Target
+236.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eupraxia Pharmaceuticals Inc.

Raymond James

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Consensus Eupraxia Pharmaceuticals Inc.